1504TiPNintedanib plus docetaxel in routine clinical practice: VARGADO, a German prospective non-interventional study (NIS) reflecting routine treatment conditions in an evolving NSCLC treatment landscape. (23rd October 2018) - Grohe, C; Zander, I; Lüdtke-Heckenkamp, K; Blau, W; Krüger, S; Franke, C; Mueller-Huesmann, H; Brückl, W M; Basara, N; Ukena, D; Lang, S; Atz, J; et al.